Published in J Biol Chem on October 25, 2002
Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog (2010) 1.02
Mutagenesis and evolution of sulfated antibodies using an expanded genetic code. Biochemistry (2009) 0.88
Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function. BMC Evol Biol (2007) 0.85
Ezrin-radixin-moesin-binding sequence of PSGL-1 glycoprotein regulates leukocyte rolling on selectins and activation of extracellular signal-regulated kinases. J Biol Chem (2012) 0.84
Human L-selectin preferentially binds synthetic glycosulfopeptides modeled after endoglycan and containing tyrosine sulfate residues and sialyl Lewis x in core 2 O-glycans. Glycobiology (2010) 0.82
Tyrosine replacement of PSGL-1 reduces association kinetics with P- and L-selectin on the cell membrane. Biophys J (2012) 0.81
Molecular cloning and expression analysis of P-selectin glycoprotein ligand-1 from zebrafish (Danio rerio). Fish Physiol Biochem (2011) 0.80
Endoglycan, a member of the CD34 family of sialomucins, is a ligand for the vascular selectins. J Immunol (2008) 0.79
P-selectin glycoprotein ligand-1 decameric repeats regulate selectin-dependent rolling under flow conditions. J Biol Chem (2008) 0.78
Physiological Exploration of the Long-term Evolutionary Selection Against Expression of N-glycolylneuraminic Acid in the Brain. J Biol Chem (2017) 0.75
Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi. Cell (2003) 3.75
The genome of Tetranychus urticae reveals herbivorous pest adaptations. Nature (2011) 3.29
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet (2011) 3.10
SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem (2011) 2.74
SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res (2011) 2.46
Inhibition of the shade avoidance response by formation of non-DNA binding bHLH heterodimers. EMBO J (2009) 2.20
The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem (2007) 1.89
Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization. PLoS One (2012) 1.77
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination. J Clin Invest (2009) 1.71
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol Rev (2002) 1.58
Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochim Biophys Acta (2007) 1.50
Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor. J Clin Oncol (2008) 1.50
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab. Cancer Immunol Immunother (2013) 1.42
Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1. J Clin Endocrinol Metab (2003) 1.41
Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities. J Virol (2010) 1.40
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function. J Immunol (2010) 1.33
Structural prediction of peptides bound to MHC class I. J Mol Biol (2005) 1.33
Type II phosphatidylinositol 4-kinase beta is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP. J Biol Chem (2002) 1.33
Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma. J Clin Oncol (2013) 1.31
The DOF protein, SAD, interacts with GAMYB in plant nuclei and activates transcription of endosperm-specific genes during barley seed development. Plant J (2005) 1.27
Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression. Clin Cancer Res (2013) 1.25
Fast docking using the CHARMM force field with EADock DSS. J Comput Chem (2011) 1.25
Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex. Proteins (2007) 1.25
Model structure of human APOBEC3G. PLoS One (2007) 1.24
Rational design of indoleamine 2,3-dioxygenase inhibitors. J Med Chem (2010) 1.22
CD3 delta establishes a functional link between the T cell receptor and CD8. J Biol Chem (2002) 1.20
CD8+ cytotoxic T lymphocyte activation by soluble major histocompatibility complex-peptide dimers. J Biol Chem (2005) 1.18
A combined computational and functional approach identifies new residues involved in pH-dependent gating of ASIC1a. J Biol Chem (2010) 1.17
Role of Gas6 in erythropoiesis and anemia in mice. J Clin Invest (2008) 1.16
Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness. J Biol Chem (2012) 1.16
The V-ATPase proteolipid cylinder promotes the lipid-mixing stage of SNARE-dependent fusion of yeast vacuoles. EMBO J (2011) 1.12
Functional dynamics of PDZ binding domains: a normal-mode analysis. Biophys J (2005) 1.11
Shaping the interaction landscape of bioactive molecules. Bioinformatics (2013) 1.09
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient. Melanoma Res (2014) 1.08
Silencing of both beta-TrCP1 and HOS (beta-TrCP2) is required to suppress human immunodeficiency virus type 1 Vpu-mediated CD4 down-modulation. J Virol (2006) 1.08
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J Immunol (2003) 1.07
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions. Blood (2006) 1.07
Generation and phenotypic analysis of protein S-deficient mice. Blood (2009) 1.06
Pulmonary sarcoid-like granulomatosis induced by ipilimumab. J Clin Oncol (2012) 1.06
Regulation of PSGL-1 interactions with L-selectin, P-selectin, and E-selectin: role of human fucosyltransferase-IV and -VII. J Biol Chem (2004) 1.05
Structural and functional interaction sites between Na,K-ATPase and FXYD proteins. J Biol Chem (2004) 1.03
SAD: a new DOF protein from barley that activates transcription of a cathepsin B-like thiol protease gene in the aleurone of germinating seeds. Plant J (2003) 1.02
Expression of a barley cystatin gene in maize enhances resistance against phytophagous mites by altering their cysteine-proteases. Plant Cell Rep (2010) 1.02
Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients. Eur J Immunol (2012) 1.01
EADock: docking of small molecules into protein active sites with a multiobjective evolutionary optimization. Proteins (2007) 1.00
Protein-protein interaction investigated by steered molecular dynamics: the TCR-pMHC complex. Biophys J (2008) 1.00
Defining and searching for structural motifs using DeepView/Swiss-PdbViewer. BMC Bioinformatics (2012) 1.00
SHP-1 phosphatase activity counteracts increased T cell receptor affinity. J Clin Invest (2013) 1.00
Hypertonic stress increases phosphatidylinositol 4,5-bisphosphate levels by activating PIP5KIbeta. J Biol Chem (2006) 1.00
Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells. Int J Cancer (2011) 0.99
SwissSidechain: a molecular and structural database of non-natural sidechains. Nucleic Acids Res (2012) 0.99
The fourth transmembrane segment of the Na,K-ATPase alpha subunit: a systematic mutagenesis study. J Biol Chem (2004) 0.99
SwissBioisostere: a database of molecular replacements for ligand design. Nucleic Acids Res (2012) 0.98
Docking, virtual high throughput screening and in silico fragment-based drug design. J Cell Mol Med (2009) 0.98
Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement. Leuk Res (2007) 0.98
A barley cysteine-proteinase inhibitor reduces the performance of two aphid species in artificial diets and transgenic Arabidopsis plants. Transgenic Res (2010) 0.97
Sequence determinants of a microtubule tip localization signal (MtLS). J Biol Chem (2012) 0.95
Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues. Proc Natl Acad Sci U S A (2008) 0.94
How T cell receptors interact with peptide-MHCs: a multiple steered molecular dynamics study. Proteins (2011) 0.94
Blind docking of 260 protein-ligand complexes with EADock 2.0. J Comput Chem (2009) 0.93
A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide. J Immunol (2007) 0.92
Cysteine peptidases and their inhibitors in Tetranychus urticae: a comparative genomic approach. BMC Genomics (2012) 0.92
Structural and functional diversity within the cystatin gene family of Hordeum vulgare. J Exp Bot (2006) 0.90
HvMCB1, a R1MYB transcription factor from barley with antagonistic regulatory functions during seed development and germination. Plant J (2006) 0.89
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncol Rep (2012) 0.89
Expanding molecular modeling and design tools to non-natural sidechains. J Comput Chem (2012) 0.89
Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer Res (2012) 0.89
RNA pentaloop structures as effective targets of regulators belonging to the RsmA/CsrA protein family. RNA Biol (2013) 0.89
Acute myeloid leukemia with myeloid sarcoma and eosinophilia: prolonged remission and molecular response to imatinib. J Clin Oncol (2009) 0.88
Dermatomyositis, lobar panniculitis and inflammatory myopathy with abundant macrophages. Neuromuscul Disord (2006) 0.87
Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood (2006) 0.87
Frequent MAGE mutations in human melanoma. PLoS One (2010) 0.87
Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferator-activated receptor alpha helix 12 dynamic behavior. J Biol Chem (2007) 0.87
Unique spectrum of activity of prosimian TRIM5alpha against exogenous and endogenous retroviruses. J Virol (2011) 0.87
Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease. Clin Transplant (2009) 0.86
A cathepsin F-like peptidase involved in barley grain protein mobilization, HvPap-1, is modulated by its own propeptide and by cystatins. J Exp Bot (2012) 0.86
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome. Leuk Res (2007) 0.86
Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function. BMC Evol Biol (2007) 0.85
Gene pyramiding of peptidase inhibitors enhances plant resistance to the spider mite Tetranychus urticae. PLoS One (2012) 0.85
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition. J Med Chem (2012) 0.85
NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-alpha and IFN-gamma in HUVEC. Regul Pept (2003) 0.85
TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires. PLoS One (2011) 0.85
In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1. Biopharm Drug Dispos (2008) 0.85
Role of the growth arrest-specific gene 6 (gas6) product in thrombus stabilization. Blood Cells Mol Dis (2006) 0.84
Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor. Thromb Haemost (2004) 0.84
Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib. Lung Cancer (2013) 0.84
Ezrin-radixin-moesin-binding sequence of PSGL-1 glycoprotein regulates leukocyte rolling on selectins and activation of extracellular signal-regulated kinases. J Biol Chem (2012) 0.84
Homology-based identification of capsid determinants that protect HIV1 from human TRIM5α restriction. J Biol Chem (2010) 0.84
BAF complex is closely related to and interacts with NF1/CTF and RNA polymerase II in gene transcriptional activation. Acta Biochim Biophys Sin (Shanghai) (2005) 0.83
Effects of myofascial release after high-intensity exercise: a randomized clinical trial. J Manipulative Physiol Ther (2008) 0.83
Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients. Cancer Immunol Immunother (2007) 0.83
Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine. Haematologica (2012) 0.83
Use of the FACTS solvation model for protein-ligand docking calculations. Application to EADock. J Mol Recognit (2010) 0.83